Perepelov Andrei V, Rózalski Antoni, Bartodziejska Beata, Senchenkova Sof'ya N, Knirel Yuriy A
N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):188-96.
Bacteria of the genus Proteus are a common cause of urinary tract infections. The O-polysaccharide chain of their LPS (O-antigen) defines the serological specificity of these bacteria. Based on the immunospecificity of the O-antigens, two species, P. mirabilis and P. vulgaris, were classified into 49 O-serogroups, and more O-serogroups for strains of these species and P. penneri have been subsequently proposed.
The lipopolysaccharide of P.mirabilis CCUG 19011 from serogroup O19 was degraded under mildly acidic and mildly alkaline conditions. Polysaccharides thus obtained were studied by chemical methods, including O -deacetylation, sugar and methylation analyses, and 1H- and 13C-NMR spectroscopy. Antisera were obtained by immunization of New Zealand white rabbits with heat-killed bacteria. In serological studies, enzyme immunosorbent assay, passive hemolysis test, and inhibition of passive hemolysis were used.
The following structure of the O-polysaccharide repeating unit was established:-->3)- beta-D-GlcrhoNAc-(1-->3)- alpha-D-GalrhoNAc4,6(R-Pyr)-(1-->4)- a-D-GalrhoA-(1-->3) alpha-L-Rhap2Ac-(1-->where R-Pyr is (R)-1-carboxyethylidene (an acetal-linked pyruvic acid). This structure is significantly different from the O-polysaccharide structures of P. vulgaris, P.hauseri and P. penneri strains from the same Proteus serogroup O19.
Based on immunochemical studies of the lipopolysaccharides, it is suggested 1) to keep P. vulgaris CCUG 4654 and P. penneri 31 in serogroup O19 as two subgroups, 2) to reclassify P. mirabilis CCUG 19011 into a new Proteus serogroup, O51, and 3) to classify serologically related strains, including P. vulgaris ATCC 49990, P. hauseri> 1732-80 and 1086-80, P. penneri 15, and some other P. penneri strains, in yet another Proteus serogroup, O52.
变形杆菌属细菌是尿路感染的常见病因。其脂多糖(O抗原)的O -多糖链决定了这些细菌的血清学特异性。基于O抗原的免疫特异性,奇异变形杆菌和普通变形杆菌这两个菌种被分为49个O血清群,随后又提出了更多针对这些菌种及潘氏变形杆菌菌株的O血清群。
来自O19血清群的奇异变形杆菌CCUG 19011的脂多糖在轻度酸性和轻度碱性条件下进行降解。通过化学方法研究所得多糖,包括O -脱乙酰化、糖和甲基化分析以及1H -和13C -核磁共振光谱。通过用热灭活细菌免疫新西兰白兔获得抗血清。在血清学研究中,使用酶免疫吸附测定、被动溶血试验和被动溶血抑制试验。
确定了O -多糖重复单元的以下结构:→3)-β - D -葡糖胺 - (1→3)-α - D -半乳糖胺4,6( R -吡喃基)-(1→4)-α - D -半乳糖醛酸-(1→3)-α - L -鼠李糖2 -乙酸酯-(1→,其中R -吡喃基为(R)-1 -羧基亚乙基(一种缩醛连接的丙酮酸)。该结构与来自同一变形杆菌O19血清群的普通变形杆菌、豪泽变形杆菌和潘氏变形杆菌菌株的O -多糖结构有显著差异。
基于脂多糖的免疫化学研究,建议:1)将普通变形杆菌CCUG 4654和潘氏变形杆菌31保留在O19血清群中作为两个亚群;2)将奇异变形杆菌CCUG 19011重新分类为一个新的变形杆菌血清群,O51;3)将血清学相关菌株,包括普通变形杆菌ATCC 49990、豪泽变形杆菌>1732 - 80和1086 - 80、潘氏变形杆菌15以及其他一些潘氏变形杆菌菌株,分类到另一个变形杆菌血清群,O52。